Related Experiment Video

Updated: Aug 13, 2026

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Prediction of anticancer drug potency from expression of genes involved in growth factor signaling

Zunyan Dai1, Catalin Barbacioru, Ying Huang

  • 1Program of Pharmacogenomics, Department of Pharmacology, The Ohio State University, 5078 Graves Hall, 333 West 10th Avenue, Columbus, 43210, USA.

Pharmaceutical Research
|January 21, 2006
PubMed
Abstract

Insights

This study identifies a small set of biomarker genes that predict anticancer drug effectiveness in tumor cells. This approach aids in discovering new biomarkers for cancer chemotherapy and genome-wide analysis.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Predicting anticancer drug efficacy is crucial for personalized medicine.
  • Identifying reliable biomarkers can optimize treatment selection.
  • Gene expression patterns offer potential for predicting drug response.

Purpose of the Study:

  • To develop a systematic method for identifying biomarker genes predicting anticancer drug potency.
  • To focus on gene families involved in growth factor signaling.
  • To identify the minimal gene subset for optimal prediction of drug potency.

Main Methods:

  • Correlated cytotoxic potencies of 119 drugs against 60 cancer cell lines (NCI-60) with expression of 343 genes.
  • Included genes involved in growth factor signaling, metalloproteinases, and ras-like GTPases.
  • Employed progressively stringent criteria and predictive models to identify a minimal gene subset.

Main Results:

  • Identified genes with significant negative (chemoresistance) and positive (chemosensitivity) correlations with drug potency.
  • Validated the approach with known chemoresistance factors.
  • Discovered a 13-gene subset sufficient for near-optimal prediction of drug potency.
  • Observed distinct expression profiles and drug correlations for EGFR and ERBB2, with no observed synergism between their inhibitors.

Conclusions:

  • The developed approach effectively identifies known and potential biomarkers for cancer chemotherapy.
  • A small gene subset can predict drug potency, offering a strategy for genome-wide analysis.
  • This method provides a foundation for discovering novel biomarkers in oncology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...